A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : Abeta42

Search Conditions:
Search Keyword : Abeta42
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: Abeta42
Appearance Frequency: 566 time(s)
Long forms: 64

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
amyloid-beta42
(279 times)
Neurology
(138 times)
AD (184 times)
CSF (104 times)
t-tau (43 times)
1999 Evidence that Abeta42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype.
beta-amyloid 1-42
(112 times)
Neurology
(62 times)
AD (69 times)
CSF (57 times)
t-tau (25 times)
1999 Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.
amyloid-beta peptide 1-42
(35 times)
Neurology
(12 times)
AD (19 times)
CSF (4 times)
3alpha-diol (2 times)
2004 Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment.
Abeta1-42
(30 times)
Neurology
(18 times)
AD (16 times)
Abeta40 (12 times)
CSF (5 times)
2000 Immunohistochemical analysis of cerebral cortical and vascular lesions in the primate Microcebus murinus reveal distinct amyloid beta1-42 and beta1-40 immunoreactivity profiles.
amyloid beta42 protein
(17 times)
Neurology
(6 times)
AD (12 times)
CSF (4 times)
T-tau (4 times)
2001 Heritability of plasma amyloid beta in typical late-onset Alzheimer's disease pedigrees.
amyloid beta-protein 42
(9 times)
Neurology
(3 times)
AD (7 times)
CSF (2 times)
Abeta40 (1 time)
2004 Plasma levels of amyloid beta-protein 42 are increased in women with mild cognitive impairment.
beta-amyloid peptide 1-42
(9 times)
Neurology
(5 times)
AD (4 times)
CSF (3 times)
S100B (2 times)
2003 Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42.
Abeta peptide 1-42
(5 times)
Neurology
(2 times)
AD (4 times)
15-LOX (1 time)
Abeta40 (1 time)
2001 Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease.
amyloid beta peptides ending at residue 42
(4 times)
Biochemistry
(2 times)
PS (3 times)
FAD (2 times)
APPs (1 time)
1999 C terminus of presenilin is required for overproduction of amyloidogenic Abeta42 through stabilization and endoproteolysis of presenilin.
10  beta-Amyloid ((1-42)) protein
(3 times)
Neurology
(2 times)
AD (2 times)
CSF (2 times)
CVD (1 time)
2000 Cerebrospinal beta-amyloid ((1-42)) in early Alzheimer's disease: association with apolipoprotein E genotype and cognitive decline.
11  beta-amyloid 1-42 peptide
(3 times)
Alzheimer Disease
(1 time)
AD (3 times)
CSF (2 times)
t-tau (2 times)
2011 Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment.
12  beta-amyloid protein 42
(3 times)
Neurology
(2 times)
AD (2 times)
APP (2 times)
ELISA (1 time)
2002 Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.
13  after the last dose to measure drug levels, beta-amyloid1-42
(2 times)
Neurology
(2 times)
CSF (2 times)
sCD40L (2 times)
2013 CHF5074 Reduces Biomarkers of Neuroinflammation in Patients with Mild Cognitive Impairment: A 12-Week, Double-Blind, Placebo-Controlled Study.
14  aggregation of beta-amyloid 42
(2 times)
Neurology
(1 time)
--- 2008 [Current immune therapy for Alzheimer's disease].
15  Amyloid-beta peptide ending at 42nd residue
(2 times)
Molecular Biology
(2 times)
GSMs (2 times)
TMD (2 times)
AD (1 time)
2011 Phenylpiperidine-type gamma-secretase modulators target the transmembrane domain 1 of presenilin 1.
16  amyloid-beta peptides with 42 amino acid residues
(2 times)
Biochemistry
(1 time)
ACh (1 time)
AChE (1 time)
AD (1 time)
2010 Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif.
17  amyloid-peptide beta 42
(2 times)
Natural Science Disciplines
(1 time)
AD (2 times)
apo (1 time)
APOE4 (1 time)
2016 The ability of apolipoprotein E fragments to promote intraneuronal accumulation of amyloid beta peptide 42 is both isoform and size-specific.
18  42-amino-acid beta-amyloid
(1 time)
Biochemistry
(1 time)
FLIM (1 time)
SIM (1 time)
WT (1 time)
2019 Structural progression of amyloid-beta Arctic mutant aggregation in cells revealed by multiparametric imaging.
19  42-amino-acid beta-amyloid derivative
(1 time)
Science
(1 time)
--- 1999 Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants.
20  42-amino-acid form of beta-amyloid
(1 time)
Neurology
(1 time)
CSF (1 time)
p-tau (1 time)
t-tau (1 time)
2014 Cerebrospinal fluid biomarkers of neurodegeneration in patients with juvenile and classic myotonic dystrophy type 1.
21  aberrant generation of beta-amyloid-42
(1 time)
Biology
(1 time)
AD (1 time)
ncRNA (1 time)
2017 Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer's disease: An integrative review.
22  Abeta 1-42 peptide
(1 time)
Neurology
(1 time)
AD (1 time)
APP (1 time)
CA (1 time)
2013 Carnosic acid suppresses the production of amyloid-beta 1-42 by inducing the metalloprotease gene TACE/ADAM17 in SH-SY5Y human neuroblastoma cells.
23  Abeta aa 1-42
(1 time)
Biology
(1 time)
AD (1 time)
ApoER2 (1 time)
CTFs (1 time)
2018 Decreased generation of C-terminal fragments of ApoER2 and increased reelin expression in Alzheimer's disease.
24  Abeta ending at amino acid 42
(1 time)
Neurology
(1 time)
8OHG (1 time)
DS (1 time)
2000 Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome.
25  Abeta ending at residue 42
(1 time)
Biochemistry
(1 time)
FAD (1 time)
HL (1 time)
PS (1 time)
2000 The nonconserved hydrophilic loop domain of presenilin (PS) is not required for PS endoproteolysis or enhanced abeta 42 production mediated by familial early onset Alzheimer's disease-linked PS variants.
26  Abeta of 42 residues
(1 time)
Biology
(1 time)
APP (1 time)
GGPP (1 time)
HMG (1 time)
2008 Geranylgeranyl pyrophosphate stimulates gamma-secretase to increase the generation of Abeta and APP-CTFgamma.
27  Abeta production, specifically its highly amyloidogenic 42 amino acid variant
(1 time)
Neurology
(1 time)
AD (1 time)
betaAPP (1 time)
FAD (1 time)
1999 Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.
28  Abeta, the one of 42aa length
(1 time)
Biochemistry
(1 time)
--- 2011 Toxicity of Alzheimer's disease-associated Abeta peptide is ameliorated in a Drosophila model by tight control of zinc and copper availability.
29  Abnormal CSF beta-amyloid 1-42
(1 time)
Neurology
(1 time)
AD (1 time)
MCI (1 time)
SCD (1 time)
2015 Subjective cognitive decline is related to CSF biomarkers of AD in patients with MCI.
30  Abnormal interaction of beta-amyloid 42
(1 time)
Geriatrics
(1 time)
AD (1 time)
IDE (1 time)
2009 Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid.
31  accumulation of extracellular beta amyloid peptide 42
(1 time)
Environmental Health
(1 time)
CBMN-Cyt (1 time)
CIR (1 time)
HS (1 time)
2014 Extracellular amyloid beta 42 causes necrosis, inhibition of nuclear division, and mitotic disruption under both folate deficient and folate replete conditions as measured by the cytokinesis-block micronucleus cytome assay.
32  accuracy of CSF beta-amyloid(1-42)
(1 time)
Medicine
(1 time)
AD (1 time)
CI (1 time)
CSF (1 time)
2009 CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
33  AD, decreased CSF beta-amyloid 1-42
(1 time)
Biology
(1 time)
AD (1 time)
alpha-Syn (1 time)
CSF (1 time)
2017 Cerebrospinal Fluid Biomarkers of Cognitive Decline in Parkinson's Disease.
34  AD: (1) cognitively healthy elderly with normal CSF beta-amyloid 42
(1 time)
Neurology
(1 time)
AD (1 time)
mI (1 time)
MRS (1 time)
2016 Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.
35  AD: beta-amyloid42
(1 time)
Chemistry, Clinical
(1 time)
AD (1 time)
CSF (1 time)
P-tau (1 time)
2003 Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers.
36  age of 59, with reduced beta-amyloid1-42
(1 time)
Neurology
(1 time)
AD (1 time)
CERAD (1 time)
FTDP-17 (1 time)
2015 Frontotemporal dementia with parkinsonism linked to chromosome 17 with the MAPT R406W mutation presenting with a broad distribution of abundant senile plaques.
37  agents were tethered to the C-terminus of beta-amyloid peptide 1-42
(1 time)
Nanotechnology
(1 time)
STM (1 time)
2014 Molecular tethering effect of C-terminus of amyloid peptide abeta42.
38  alpha-synuclein, beta-amyloid42
(1 time)
Neurology
(1 time)
AD (1 time)
DLB (1 time)
SNCA (1 time)
2010 Differential levels of alpha-synuclein, beta-amyloid42 and tau in CSF between patients with dementia with Lewy bodies and Alzheimer's disease.
39  Although reduced CSF beta-amyloid1-42
(1 time)
Nervous System Diseases
(1 time)
AD (1 time)
BBB (1 time)
CSF (1 time)
2017 Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson's Disease Patients.
40  Alzheimer's biomarkers beta amyloid 1-42
(1 time)
Zoology
(1 time)
p-tau (1 time)
t-tau (1 time)
2013 Correlations between serum levels of beta amyloid, cerebrospinal levels of tau and phospho tau, and delayed response tasks in young and aged cynomolgus monkeys (Macaca fascicularis).
41  amyloid beta 1-42 ((1)DAEFRHDSG(10)YEVHHQKLVF(20)FAEDVGSNKG(30)AIIGLMVGGV(40)VIA)
(1 time)
Biochemistry
(1 time)
--- 2015 The membrane-active amphibian peptide caerin 1.8 inhibits fibril formation of amyloid beta1-42.
42  Amyloid beta 1-42 oligomers
(1 time)
Brain
(1 time)
NMDARs (1 time)
RyRs (1 time)
VGCCs (1 time)
2018 Early Alterations of Hippocampal Neuronal Firing Induced by Abeta42.
43  amyloid beta peptides of the 1-42 species
(1 time)
Neurology
(1 time)
--- 2003 CCR1 is an early and specific marker of Alzheimer's disease.
44  amyloid beta protein ending at amino acid 42
(1 time)
Neurology
(1 time)
AD (1 time)
APOE (1 time)
CSF (1 time)
1998 High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.
45  amyloid beta protein, especially those ending at the 42nd residue
(1 time)
Geriatrics
(1 time)
FAD (1 time)
1998 Abeta42, presenilins, and Alzheimer's disease.
46  amyloid beta, isoform 42
(1 time)
Molecular Biology
(1 time)
AD (1 time)
GSK3beta (1 time)
IDE (1 time)
2017 Pioglitazone ameliorates Abeta42 deposition in rats with diet-induced insulin resistance associated with AKT/GSK3beta activation.
47  Amyloid beta-protein ending at 42
(1 time)
Neurology
(1 time)
AD (1 time)
2007 Intraneuronal amyloid beta42 enhanced by heating but counteracted by formic acid.
48  amyloid beta-protein, particularly the 42-residue alloform
(1 time)
Chemistry Techniques, Analytical
(1 time)
AD (1 time)
AFM (1 time)
IM-MS (1 time)
2019 Inhibiting and Remodeling Toxic Amyloid-Beta Oligomer Formation Using a Computationally Designed Drug Molecule That Targets Alzheimer's Disease.
49  amyloid-beta consisting of 42 amino acids
(1 time)
Biochemistry
(1 time)
AD (1 time)
CSF (1 time)
p-tau (1 time)
2017 Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: an update.
50  amyloid-beta peptide 1-42 oligomers
(1 time)
Neurology
(1 time)
AD (1 time)
LPS (1 time)
NF-kappaB (1 time)
2019 Lipid transporter Spns2 promotes microglia pro-inflammatory activation in response to amyloid-beta peptide.
51  Amyloid-beta peptides such as Abeta1-42
(1 time)
Geriatrics
(1 time)
AD (1 time)
RBL (1 time)
2015 The chemerin receptor CMKLR1 is a functional receptor for amyloid-beta peptide.
52  amyloid-beta protein terminating at position 42
(1 time)
Geriatrics
(1 time)
AD (1 time)
2017 A Method for Diagnosing Alzheimer's Disease Based on Salivary Amyloid-beta Protein 42 Levels.
53  amyloid-beta1 to 42
(1 time)
Neurology
(1 time)
AD (1 time)
CSF (1 time)
PET (1 time)
2010 Dementia mimicking Alzheimer's disease Owing to a tau mutation: CSF and PET findings.
54  analysed CSF concentrations of beta amyloid(1-42)
(1 time)
Neurology
(1 time)
MCI (1 time)
t-tau (1 time)
2006 Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.
55  analysed for beta-amyloid(1-42)
(1 time)
Geriatrics
(1 time)
AD (1 time)
p-tau (1 time)
rCBF (1 time)
2012 CSF biomarkers correlate with cerebral blood flow on SPECT in healthy elderly.
56  analyzed for MMP-1, MMP-3, MMP-9, TIMP-1, beta-amyloid1-42
(1 time)
Alzheimer Disease
(1 time)
AD (1 time)
CSF (1 time)
MMP (1 time)
2010 Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer's disease.
57  anti-amyloid beta protein 1-42
(1 time)
Veterinary Medicine
(1 time)
Abeta40 (1 time)
AD (1 time)
APP Tg-mouse (1 time)
2012 Binding of curcumin to senile plaques and cerebral amyloid angiopathy in the aged brain of various animals and to neurofibrillary tangles in Alzheimer's brain.
58  beta-amyloid peptide of 42 residues
(1 time)
Medicine
(1 time)
AD (1 time)
2011 The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease.
59  beta-amyloid peptide with 42 amino acids
(1 time)
Geriatrics
(1 time)
ALS (1 time)
CSF (1 time)
FTD (1 time)
2017 Cerebrospinal Fluid TAR DNA-Binding Protein 43 Combined with Tau Proteins as a Candidate Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Spectrum Disorders.
60  beta-amyloid protein ending at amino acid 42
(1 time)
Neurology
(1 time)
AD (1 time)
CSF (1 time)
2001 Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice.
61  beta-amyloid-42 fragment
(1 time)
Neurology
(1 time)
AD (1 time)
CSF (1 time)
p-tau (1 time)
2017 Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer's disease.
62  beta-amyloid42 deposition
(1 time)
Geriatrics
(1 time)
NFL (1 time)
total tau (1 time)
WMHs (1 time)
2018 Cerebrospinal fluid beta-amyloid42 and neurofilament light relate to white matter hyperintensities.
63  binding assay against beta-amyloid 1-42
(1 time)
Biochemistry
(1 time)
AD (1 time)
PiB (1 time)
SBO (1 time)
2008 Synthesis and evaluation of stilbenylbenzoxazole and stilbenylbenzothiazole derivatives for detecting beta-amyloid fibrils.
64  biomarkers-beta-amyloid 1-42
(1 time)
Nervous System Diseases
(1 time)
AD (1 time)
CSF (1 time)
MMSE (1 time)
2014 Differential role of CSF alpha-synuclein species, tau, and Abeta42 in Parkinson's Disease.